Physician profile
Uday Devgan
NPI 1801831219
$189,251.03
in general payments reported to CMS, 2019-2025
25 companies · $953 in 2025
The $953 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $240 · 2021: $2,124 · 2022: $2,326 · 2023: $1,110 · 2024: $151K · 2025: $953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $150K · Food and Beverage: $3,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $150,000.00 |
| Food and Beverage | $3,349.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $150,000.00 | 2024 | Iheezo |
| Novartis Pharmaceuticals Corporation | $22,392.33 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $8,334.56 | 2019-2021 | |
| Alcon Vision LLC | $2,657.45 | 2019-2025 | Clareon, Unity, Eysuvis |
| Sun Pharmaceutical Industries INC. | $1,251.77 | 2019-2025 | Cequa, Bromsite, Xelpros |
| Carl Zeiss Meditec USA, INC. | $934.91 | 2021-2023 | Quatera 700, Clarus, Lumera 700 |
| Bausch & Lomb Americas INC. | $893.87 | 2022-2024 | Xiidra, Miebo, Lotemax Sm |
| Johnson & Johnson Surgical Vision, INC. | $531.08 | 2019-2023 | Tecnis Simplicity |
| Carl Zeiss Meditec, INC. | $331.54 | 2019-2022 | |
| Abbvie INC. | $291.07 | 2022-2025 | |
| Microsurgical Technology, INC. | $265.23 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $249.53 | 2024 | Xdemvy |
| Rxsight INC | $187.15 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Glaukos Corporation | $165.63 | 2019 | |
| Sight Sciences, INC. | $159.67 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $127.75 | 2022 | |
| Csl Behring | $124.98 | 2024 | Kcentra |
| Dompe US, INC. | $101.88 | 2022-2025 | Oxervate |
| Eyevance Pharmaceuticals LLC | $63.32 | 2019-2020 | |
| Allergan, INC. | $50.84 | 2021 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Shire North American Group INC | $28.61 | 2019 | |
| Rayner Intraocular Lenses Limited | $27.86 | 2022 | |
| Quidel Corporation | $24.31 | 2019 | |
| New World Medical,INC. | $16.89 | 2024 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uday Devgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.